{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:16:31Z","timestamp":1774440991683,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00432-017-2422-6","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T11:55:01Z","timestamp":1493207701000},"page":"1833-1844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes"],"prefix":"10.1007","volume":"143","author":[{"given":"Miriam","family":"Rottmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Burges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Anthuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Grab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schnelzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kiechle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"P\u00f6lcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schubert-Fritschle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"2422_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.06.013","author":"B Ataseven","year":"2016","unstructured":"Ataseven B, Chiva LM, Harter P, Gonzalez-Martin A, du Bois A (2016) FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited. Gynecol Oncol. doi:\n                        10.1016\/j.ygyno.2016.06.013","journal-title":"Gynecol Oncol"},{"key":"2422_CR3","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.ejca.2011.09.023","volume":"48","author":"A Bamias","year":"2012","unstructured":"Bamias A et al (2012) Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel\/carboplatin chemotherapy: cell type is the most useful prognostic factor. Eur J Cancer (Oxford, England: 1990) 48:1476\u20131483. doi:\n                        10.1016\/j.ejca.2011.09.023","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"Suppl 2","key":"2422_CR4","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.ijgo.2015.06.007","volume":"131","author":"JS Berek","year":"2015","unstructured":"Berek JS, Crum C, Friedlander M (2015) Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 131(Suppl 2):S111\u2013S122. doi:\n                        10.1016\/j.ijgo.2015.06.007","journal-title":"Int J Gynaecol Obstet"},{"key":"2422_CR5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/bjc.2011.455","volume":"105","author":"EI Braicu","year":"2011","unstructured":"Braicu EI, Sehouli J, Richter R, Pietzner K, Denkert C, Fotopoulou C (2011) Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Br J Cancer 105:1818\u20131824. doi:\n                        10.1038\/bjc.2011.455","journal-title":"Br J Cancer"},{"key":"2422_CR6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259","journal-title":"J Clin Oncol"},{"key":"2422_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","volume":"130","author":"SJ Chang","year":"2013","unstructured":"Chang SJ, Hodeib M, Chang J, Bristow RE (2013) Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol 130:493\u2013498. doi:\n                        10.1016\/j.ygyno.2013.05.040","journal-title":"Gynecol Oncol"},{"key":"2422_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2013.03.004","volume":"88","author":"G Chene","year":"2013","unstructured":"Chene G, Dauplat J, Radosevic-Robin N, Cayre A, Penault-Llorca F (2013) Tu-be or not tu-be: that is the question\u2026 about serous ovarian carcinogenesis. Crit Rev Oncol Hematol 88:134\u2013143. doi:\n                        10.1016\/j.critrevonc.2013.03.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"2422_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois du","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer 115:1234\u20131244. doi:\n                        10.1002\/cncr.24149","journal-title":"Cancer"},{"key":"2422_CR10","unstructured":"Ederer F, Heise H (1959) Instructions to IBM 650 programmers in processing survival computations. Methodological Note No. 10. End Results Evaluation Section. National Cancer Institute"},{"key":"2422_CR11","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386. doi:\n                        10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"2422_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ygyno.2016.06.023","volume":"142","author":"B Gao","year":"2016","unstructured":"Gao B et al (2016) Serous ovarian and primary peritoneal cancers: a comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome. Gynecol Oncol 142:458\u2013464. doi:\n                        10.1016\/j.ygyno.2016.06.023","journal-title":"Gynecol Oncol"},{"key":"2422_CR13","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1200\/jco.2015.61.0873","volume":"33","author":"DM Gershenson","year":"2015","unstructured":"Gershenson DM et al (2015) Impact of age and primary disease site on outcome in women with low-grade serous carcinoma of the ovary or peritoneum: results of a large single-institution registry of a rare tumor. J Clin Oncol 33:2675\u20132682. doi:\n                        10.1200\/jco.2015.61.0873","journal-title":"J Clin Oncol"},{"key":"2422_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fonc.2016.00063","volume":"6","author":"SJ Gibson","year":"2016","unstructured":"Gibson SJ, Fleming GF, Temkin SM, Chase DM (2016) The application and outcome of standard of care treatment in elderly women with ovarian cancer: a literature review over the last 10 years. Front Oncol 6:63. doi:\n                        10.3389\/fonc.2016.00063","journal-title":"Front Oncol"},{"key":"2422_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ygyno.2016.01.022","volume":"140","author":"JP Grabowski","year":"2016","unstructured":"Grabowski JP et al (2016) Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase. Gynecol Oncol 140:457\u2013462. doi:\n                        10.1016\/j.ygyno.2016.01.022","journal-title":"Gynecol Oncol"},{"key":"2422_CR16","volume-title":"The statistical analysis of failure time data","author":"J Kalbfleisch","year":"1980","unstructured":"Kalbfleisch J, Prentice R (1980) The statistical analysis of failure time data. Wiley, New York"},{"key":"2422_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.08.320","author":"A Kaldawy","year":"2016","unstructured":"Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA (2016) Low-grade serous ovarian cancer: a review. Gynecol Oncol. doi:\n                        10.1016\/j.ygyno.2016.08.320","journal-title":"Gynecol Oncol"},{"key":"2422_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2016.07.015","volume":"66","author":"M Kleppe","year":"2016","unstructured":"Kleppe M, van der Aa MA, Van Gorp T, Slangen BF, Kruitwagen RF (2016) The impact of lymph node dissection and adjuvant chemotherapy on survival: a nationwide cohort study of patients with clinical early-stage ovarian cancer. Eur J Cancer (Oxford, England: 1990) 66:83\u201390. doi:\n                        10.1016\/j.ejca.2016.07.015","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"2422_CR19","volume-title":"WHO classification of tumour of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014) WHO classification of tumour of female reproductive organs, 4th edn. International Agency for Research on Cancer, Lyon","edition":"4"},{"key":"2422_CR20","unstructured":"Munich Cancer Registry (2016) Catchment area of MCR. \n                        http:\/\/www.tumorregister-muenchen.de\/en\/area.php\n                        \n                    . Accessed 4 Oct 2016"},{"key":"2422_CR1","doi-asserted-by":"publisher","unstructured":"Rauh-Hain JA et al (2015) Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer. Am J Obstet Gynecol 212:600.e601\u2013608. doi:\n                        10.1016\/j.ajog.2014.12.013","DOI":"10.1016\/j.ajog.2014.12.013"},{"key":"2422_CR21","unstructured":"Robert Koch Institute (RKI) (2014) Cancer in Germany 2009\/2010, 9th edn. German Centre for Cancer Registry Data (ZfKD). \n                        http:\/\/www.krebsdaten.de\/Krebs\/EN\n                        \n                    . Accessed 5 Oct 2016"},{"key":"2422_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.022","author":"M Sant","year":"2015","unstructured":"Sant M et al (2015) Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: results of the EUROCARE-5 study. Eur J Cancer (Oxford, England: 1990). doi:\n                        10.1016\/j.ejca.2015.07.022","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"2422_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ygyno.2014.08.020","volume":"135","author":"TH Schnack","year":"2014","unstructured":"Schnack TH, Sorensen RD, Nedergaard L, Hogdall C (2014) Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology\u2014a prospective comparative study. Gynecol Oncol 135:278\u2013284. doi:\n                        10.1016\/j.ygyno.2014.08.020","journal-title":"Gynecol Oncol"},{"key":"2422_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","volume":"120","author":"JD Seidman","year":"2011","unstructured":"Seidman JD, Zhao P, Yemelyanova A (2011) \u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol 120:470\u2013473. doi:\n                        10.1016\/j.ygyno.2010.11.020","journal-title":"Gynecol Oncol"},{"key":"2422_CR25","volume-title":"TNM classification of malignant tumours. International union against cancer (UICC)","author":"L Sobin","year":"2009","unstructured":"Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours. International union against cancer (UICC), 7th edn. Wiley-Liss, New York","edition":"7"},{"key":"2422_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ygyno.2015.01.534","volume":"136","author":"RD Sorensen","year":"2015","unstructured":"Sorensen RD, Schnack TH, Karlsen MA, Hogdall CK (2015) Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities\u2014a systematic review. Gynecol Oncol 136:571\u2013581. doi:\n                        10.1016\/j.ygyno.2015.01.534","journal-title":"Gynecol Oncol"},{"key":"2422_CR27","doi-asserted-by":"publisher","unstructured":"Usach I, Blansit K, Chen LM, Ueda S, Brooks R, Kapp DS, Chan JK (2015) Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas. Am J Obstet Gynecol 212:188.e181\u2013186. doi:\n                        10.1016\/j.ajog.2014.08.016","DOI":"10.1016\/j.ajog.2014.08.016"},{"key":"2422_CR28","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/cncr.23957","volume":"113","author":"SL Wethington","year":"2008","unstructured":"Wethington SL et al (2008) Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. Cancer 113:3298\u20133306. doi:\n                        10.1002\/cncr.23957","journal-title":"Cancer"},{"key":"2422_CR29","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1200\/jco.2006.10.2517","volume":"25","author":"WE Winter 3rd","year":"2007","unstructured":"Winter WE 3rd et al (2007) Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25:3621\u20133627. doi:\n                        10.1200\/jco.2006.10.2517","journal-title":"J Clin Oncol"},{"key":"2422_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejca.2016.03.008","volume":"60","author":"H Woopen","year":"2016","unstructured":"Woopen H, Inci G, Richter R, Chekerov R, Ismaeel F, Sehouli J (2016) Elderly ovarian cancer patients: an individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO). Eur J Cancer (Oxford, England: 1990) 60:101\u2013106. doi:\n                        10.1016\/j.ejca.2016.03.008","journal-title":"Eur J Cancer (Oxford, England: 1990)"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-017-2422-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2422-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2422-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T07:45:10Z","timestamp":1503301510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-017-2422-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["2422"],"URL":"https:\/\/doi.org\/10.1007\/s00432-017-2422-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}